DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS

Clinical trials for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS explained in plain language.

Never miss a new study

Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS trials appear

Sign up with your email to follow new studies for DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Completed 1

New hope for elderly lymphoma patients: a gentler treatment that preserves independence

Disease control Completed

This phase 2 trial investigates whether combining rituximab with lenalidomide works as well as standard rituximab-based chemotherapy for patients aged 75 and older with relapsed diffuse large B-cell lymphoma. The study focuses not only on controlling the cancer but also on mainta…

Matched conditions: DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS

Phase: PHASE2 • Sponsor: Centre Hospitalier Universitaire, Amiens • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS

Get alerted when new DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL), NOS trials appear

New hope for elderly lymphoma patients: a gentler treatment that preserves independence